s'authentifier
version française rss feed
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Canzian F., Kaaks R., Cox D., Henderson K., Henderson B., Berg C., Bingham S., Boeing H., Buring J., Calle E. et al
BMC Cancer 9, 1 (2009) 257 - http://www.hal.inserm.fr/inserm-00617241
 (19640273) 
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Federico Canzian () 1, Rudolf Kaaks1, David Cox2, Katherine Henderson3, 4, Brian Henderson3, Christine Berg5, Sheila Bingham6, Heiner Boeing7, Julie Buring8, Eugenia Calle9, Stephen Chanock5, Françoise Clavel-Chapelon10, Laure Dossus1, Heather Feigelson9, Christopher Haiman3, Susan Hankinson8, Robert Hoover5, David Hunter2, Claudine Isaacs11, Per Lenner12, Eiliv Lund13, Kim Overvad14, Domenico Palli15, Celeste Pearce3, Jose Quiros16, Elio Riboli17, Daniel Stram3, Gilles Thomas5, Michael Thun9, Dimitrios Trichopoulos18, Carla van Gils19, Regina Ziegler5
1 :  DKFZ - German Cancer Research Center
DKFZ
Heidelberg
Allemagne
2 :  Harvard School of Public Health
Harvard School of Public Health
Boston, MA
États-Unis
3 :  University of Southern California
University of California, Los Angeles
Los Angeles, CA
États-Unis
4 :  Beckman Research Institute
City of Hope National Medical Center
Duarte, CA
États-Unis
5 :  Division of Cancer Epidemiology and Genetics
National Cancer Institute
Bethesda, MD
États-Unis
6 :  Dunn Human Nutrition Unit
MRC
Cambridge
Royaume-Uni
7 :  Department of Epidemiology
German Institute of Human Nutrition Potsdam-Rehbruecke
Potsdam-Rehbruecke, Nuthetal
Allemagne
8 :  HMS - Harvard Medical School
http://www.hms.harvard.edu
Harvard University
25 Shattuck Street Boston, MA 02115
États-Unis
9 :  American Cancer Society
American Cancer Society
Atlanta, GA
États-Unis
10 :  E3N - Nutrition, hormones et cancer: épidémiologie et prévention
http://www.idf.inserm.fr/site/eri20/
INSERM : ERI20 – IFR69 – Université Paris XI - Paris Sud : EA4045
Institut Gustave-Roussy 39 rue Camille Desmoulins 94805 Villejuif CEDEX
France
11 :  Lombardi Comprehensive Cancer Center
Georgetown University
Washington DC
États-Unis
12 :  Department of Radiation Sciences, Oncology
Umea University
Umeå
Suède
13 :  Institute of Community Medicine
University of Tromsø
Norvège
14 :  Department of Clinical Epidemiology
Aarhus University Hospital
Danemark
15 :  Molecular and Nutritional Epidemiology Unit
CSPO-Scientific Institute of Tuscany
Florence
Italie
16 :  Public Health and Health Planning Directorate
Public Health and Health Planning Directorate
Asturias
Espagne
17 :  Imperial College
Imperial College
London
Royaume-Uni
18 :  Department of Hygiene and Epidemiology
University of Athens
Grèce
19 :  Julius Center for Health Sciences and Primary Care
Utrecht university medical center
Pays-Bas
BACKGROUND: Gonadotropin releasing hormone (GNRH1) triggers the release of follicle stimulating hormone and luteinizing hormone from the pituitary. Genetic variants in the gene encoding GNRH1 or its receptor may influence breast cancer risk by modulating production of ovarian steroid hormones. We studied the association between breast cancer risk and polymorphisms in genes that code for GNRH1 and its receptor (GNRHR) in the large National Cancer Institute Breast and Prostate Cancer Cohort Consortium (NCI-BPC3). METHODS: We sequenced exons of GNRH1 and GNRHR in 95 invasive breast cancer cases. Resulting single nucleotide polymorphisms (SNPs) were genotyped and used to identify haplotype-tagging SNPs (htSNPS) in a panel of 349 healthy women. The htSNPs were genotyped in 5,603 invasive breast cancer cases and 7,480 controls from the Cancer Prevention Study-II (CPS-II), European Prospective Investigation on Cancer and Nutrition (EPIC), Multiethnic Cohort (MEC), Nurses' Health Study (NHS), and Women's Health Study (WHS). Circulating levels of sex steroids (androstenedione, estradiol, estrone and testosterone) were also measured in 4713 study subjects. RESULTS: Breast cancer risk was not associated with any polymorphism or haplotype in the GNRH1 and GNRHR genes, nor were there any statistically significant interactions with known breast cancer risk factors. Polymorphisms in these two genes were not strongly associated with circulating hormone levels. CONCLUSION: Common variants of the GNRH1 and GNRHR genes are not associated with risk of invasive breast cancer in Caucasians.
Sciences du Vivant/Cancérologie
Anglais
1471-2407

Articles dans des revues avec comité de lecture
10.1186/1471-2407-9-257
BMC Cancer (BMC Cancer)
Publisher BioMed Central
ISSN 1471-2407 
internationale
2009
29/07/2009
9
1
257

Breast Neoplasms – Cohort Studies – European Continental Ancestry Group – Exons – Female – Genetic Variation – Genotype – Gonadotropin-Releasing Hormone – Haplotypes – Humans – Neoplasm Invasiveness – Polymorphism – Genetic – Single Nucleotide – Prospective Studies – Protein Precursors – Receptors – LHRH
This work was funded by NCI grants U01 CA098216 (EPIC), U01CA098233 (Harvard), U01CA098758 (MEC) and U01 CA098710 (ACS)
Liste des fichiers attachés à ce document : 
PDF
1471-2407-9-257.pdf(963.7 KB)
ANNEX
1471-2407-9-257.xml(110.4 KB)
1471-2407-9-257-S1.XLS(39.5 KB)

tous les articles de la base du CCSd...